After hours: December 24 at 3:41:56 PM EST Loading Chart for CDTX ...

Last year, GSK said it was planning to invest a cool £1 billion in infectious diseases, with an emphasis on neglected tropical diseases and antimicrobial resistance (AMR). Now, its spent some of ...

After hours: December 23 at 6:32:33 p.m. EST Loading Chart for CDTX ...

a Comparison of adverse effects for all three echinocandins from their respective clinical trial for treatment of esophageal candidiasis where fluconazole was the comparator agent. Michele I ...

Purpose. The chemistry, pharmacology, spectrum of activity, resistance, pharmacokinetics, pharmacodynamics, clinical efficacy, adverse effiects, drug interactions ...